Description

Hemostasis Diagnostics Market Outline

Hemostasis diagnostics are the devices used to determine the hemostatic defects, which cause excessive bleeding. Hemostasis is defined as the stopping or slowing the blood flow from the damaged blood vessel. During the hemostasis, blood changes from liquid state to the gelatinous state. Hemostasis maintained in the body by three mechanisms namely, blood coagulation, platelet plug formation, and vasoconstriction. Hemostasis diagnostics may help to predict the cause of bleeding during surgery by identifying the hemostatic defects in patients. Different types of tests such as prothrombin test, activated clotting time, platelet function, and other coagulation tests are carried to identify the hemostasis defects.

 

Hemostasis Diagnostics Market Dynamics

 

Increase in the incidence of blood clotting disorders such as haemophilia (according to National Hemophilia Foundation, approximately 400,000 incidences of haemophilia is observed in 2012), growing number of trauma patients and surgeries, and the introduction of biodegradable and cost-effective products are expected to propel the market growth over the forecast period. Moreover, technological advancements in the hemostasis diagnostics such as accurate results in less time, increase in awareness about the hemostasis diagnostics, and rise in R&D investment for novel tests and devices boost the market. However, the high cost of advanced hemostasis products and stringent regulations for the test approvals are expected to hamper the growth of market over the forecast period.

 

The market is growing at a significant rate due to rise in the prevalence of trauma condition and various surgeries around the globe. Moreover, the rise in prevalence of cardiovascular diseases, cancer, and diabetes also expected to propel the market. Furthermore, acquisitions and mergers, collaborations, test approvals, and launchings are the strategies followed by the companies for increasing their revenue share. For instance, in January 2017, Instrumentation Laboratory, a subsidiary of Werfen has acquired Accriva Diagnostics for the expansion of its hemostasis testing portfolio. In addition, in June 2017, Grifols and Beckman Coulter entered into a distribution agreement for the distribution of Grifol’s hemostasis instruments, consumables, and reagents around the globe.

 

Hemostasis diagnostics market is segmented on the basis of product type, test type, technology, and end user

Based on the product type, the market is segmented into the following:

 

Based on the test type, the market is segmented into the following:

  • Fibrinogen Test
  • Activated Clotting Time
  • Platelet Function
  • Prothrombin Time
  • Heparin & Protamine Dose-Response Test For ACT
  • Activated Partial Thromboplastin Time
  • Anti-Factor Xa
  • Other Coagulation Tests

 

Based on technology, the market is segmented into the following:

  • Optical
  • Mechanical
  • Electrochemical
  • Others

 

Based on the end user, the market is segmented into the following:

  • Hospitals
  • Clinics
  • Diagnostic Centres
  • Others (POC)

 

Geography Analysis

 North America

  • US
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa

Rest of MEA

 

North America hemostasis diagnostics market growing at a significant rate due to well-developed healthcare infrastructure, the rise in prevalence of cardiovascular diseases (according to Centers for Disease Control and Prevention, approximately 610,000 deaths are observed due to cardiovascular diseases every year), an increase in awareness about hemostasis diagnostics are anticipated to fuel the market. Europe market driven by adoption of newer test methods in hemostasis diagnostics, increase in the prevalence of hemostasis condition (according to The European National Registry of Congenital Coagulopathies 2017, the number of cases identified with hemostasis is increased from 7000 in 2000 to 11,000 in 2015), and changes in lifestyle leads to increase in prevalence of CVDs and diabetes, which are expected to propel the market. Asia Pacific market is growing due to increase in R&D activities in Asia Pacific countries such as Japan, and improving technical capabilities. Latin America market has a prominent growth due to increase in foreign investment, development in economic growth. Middle East and Africa market is driven by an increase in the prevalence of hemostasis and other clotting diseases in African countries.

 

Competitor Analysis

 

  • Hoffmann-La Roche Ltd. (Switzerland)
  • Sysmex Corporation (Japan)
  • Abbott Laboratories (U.S.)
  • Alere Inc.  (U.S.)
  • Nihon Kohden Corporation (Japan)
  • Siemens Healthineers (Germany)
  • Grifols S.A (Spain)
  • Beckman Coulter, Inc. (U.S.)

 

Notable Market Developments:

  • In November 2016, Siemens Healthineers launched CE-marked Atellica COAG 360 system, a high-volume speciality analyzer used in the hemostasis diagnostics

 

Key Features of the Report:

  • The report provides granular level information about the market size, regional market share, historic market (2013 to 2016) and forecast (2017 to 2024)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market


Location

GEOGRAPHY

PBI Location Map

Table of Content

  1. Executive Summary
  2. Global Hemostasis Diagnostics Market Introduction
    • Global Hemostasis Diagnostics Market – Taxonomy
    • Global Hemostasis Diagnostics Market –Definitions
      • Product Type
      • Test
      • End-user
  1. Global Hemostasis Diagnostics Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Hemostasis Diagnostics Market Dynamic Factors – Impact Analysis
    • Global Hemostasis Diagnostics Market – Competition Landscape
    • Epidemiology
  2. Global Hemostasis Diagnostics Market Analysis, 2012 – 2016 and Forecast, 2018 – 2024
    • Market Analysis, 2012 – 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Hemostasis Diagnostics Market, By Product Type, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Primary Systems
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Consumables
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Point-of-Care-Testing Devices
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Hemostasis Diagnostics Market Forecast, By Test, 2013 – 2017 and Forecast, 2018 – 2024
    • Fibrinogen Test
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Activated Clotting Time
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Platelet Function
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Prothrombin Time
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Heparin & Protamine Dose-Response Test For ACT
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Activated Partial Thromboplastin Time
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Anti-Factor Xa
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Other Coagulation Tests
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Hemostasis Diagnostics Market Forecast, By Technology, 2013 – 2017 and Forecast, 2018 – 2024
    • Optical
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Mechanical
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Electrochemical
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Hemostasis Diagnostics Market Forecast, By End-user, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Hospitals
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Clinics
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Diagnostics Centers
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others (POC)
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Hemostasis Diagnostics Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Hemostasis Diagnostics Market – Opportunity Analysis Index, By Product Type, By Test, By Technology, By End-user, and Region, 2018 – 2024
  2. North America Hemostasis Diagnostics Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Systems
      • Consumables
      • Point-of-Care-Testing Devices
    • Test Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Fibrinogen Test
      • Activated Clotting Time
      • Platelet Function
      • Prothrombin Time
      • Heparin & Protamine Dose-Response Test For ACT
      • Activated Partial Thromboplastin Time
      • Anti-Factor Xa
      • Other Coagulation Tests
    • Technology Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Optical
      • Mechanical
      • Electrochemical
      • Others
    • End-Users Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Diagnostic Centers
      • Others (POC)
    • Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US.
      • Canada
    • North America Hemostasis Diagnostics Market – Opportunity Analysis Index, By Product Type, By Test, By Technology, By End-user, and Country, 2018 – 2024
    • North America Hemostasis Diagnostics Market Dynamics – Trends
  3. Europe Hemostasis Diagnostics Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Systems
      • Consumables
      • Point-of-Care-Testing Devices
    • Test Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Fibrinogen Test
      • Activated Clotting Time
      • Platelet Function
      • Prothrombin Time
      • Heparin & Protamine Dose-Response Test For ACT
      • Activated Partial Thromboplastin Time
      • Anti-Factor Xa
      • Other Coagulation Tests
    • Technology Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Optical
      • Mechanical
      • Electrochemical
      • Others
    • End-Users Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Diagnostic Centers
      • Others (POC)
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Hemostasis Diagnostics Market – Opportunity Analysis Index, By Product Type, By , By Test, By End-user, and Country, 2018 – 2024
    • Europe Hemostasis Diagnostics Market Dynamics – Trends
  4. Asia-Pacific Hemostasis Diagnostics Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Systems
      • Consumables
      • Point-of-Care-Testing Devices
    • Test Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Fibrinogen Test
      • Activated Clotting Time
      • Platelet Function
      • Prothrombin Time
      • Heparin & Protamine Dose-Response Test For ACT
      • Activated Partial Thromboplastin Time
      • Anti-Factor Xa
      • Other Coagulation Tests
    • Technology Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Optical
      • Mechanical
      • Electrochemical
      • Others
    • End-Users Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Diagnostic Centers
      • Others (POC)
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Hemostasis Diagnostics Market – Opportunity Analysis Index, By Product Type, By Technology, By Test, By End-user, and Country, 2018 – 2024
    • Asia-Pacific Hemostasis Diagnostics Market Dynamics – Trends
  5. Latin America Hemostasis Diagnostics Market Analysis, 2012 – 2012 – 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Systems
      • Consumables
      • Point-of-Care-Testing Devices
    • Test Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Fibrinogen Test
      • Activated Clotting Time
      • Platelet Function
      • Prothrombin Time
      • Heparin & Protamine Dose-Response Test For ACT
      • Activated Partial Thromboplastin Time
      • Anti-Factor Xa
      • Other Coagulation Tests
    • Technology Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Optical
      • Mechanical
      • Electrochemical
      • Others
    • End-Users Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Diagnostic Centers
      • Others (POC)
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Hemostasis Diagnostics Market – Opportunity Analysis Index, By Product Type, By Technology, By Test, By End-user, and Country, 2018 – 2024
    • Latin America Hemostasis Diagnostics Market Dynamics – Trends
  6. Middle East and Africa Hemostasis Diagnostics Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Systems
      • Consumables
      • Point-of-Care-Testing Devices
    • Test Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Fibrinogen Test
      • Activated Clotting Time
      • Platelet Function
      • Prothrombin Time
      • Heparin & Protamine Dose-Response Test For ACT
      • Activated Partial Thromboplastin Time
      • Anti-Factor Xa
      • Other Coagulation Tests
    • Technology Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Optical
      • Mechanical
      • Electrochemical
      • Others
    • End-Users Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Diagnostic Centers
      • Others (POC)
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Hemostasis Diagnostics Market – Opportunity Analysis Index, By Product Type, By Technology, By Test, By End-user, and Country, 2018 – 2024
    • MEA Hemostasis Diagnostics Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Product Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
    • Hoffmann-La Roche Ltd. (Switzerland)
    • Sysmex Corporation (Japan)
    • Abbott Laboratories (U.S.)
    • Alere Inc.  (U.S.)
    • Nihon Kohden Corporation (Japan)
    • Siemens Healthineers (Germany)
    • Grifols S.A (Spain)
    • Beckman Coulter, Inc. (U.S.)
  8. Research Methodology
  9. Key Assumptions and Acronyms

 

Disclaimer

The above mentioned segmentation is tentative; it is changed according to client’s requirement, or research feasibility.

 

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

Ask An Analyst

 

 

Request Customisation

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX